Emergent BioSolutions reports Q3 2026 revenue inline with guidance, but margins turned sharply negative
Market Chameleon (Tue, 3-Nov 9:10 AM)
Emergent BioSolutions Flags a Long-Run CFO Transition, Naming Frank Vargo Interim CFO Starting 2027
Market Chameleon (Fri, 16-Oct 8:32 AM)
